Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

NCT05451719 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Colorectal Cancer Stage IV

Interventions

DRUG: Fruquintinib Plus Capecitabine
DRUG: Capecitabine

Sponsor

Fudan University